A new study on identifying which patients were likely to have poor outcomes following a living-donor liver transplant (LDLT) found that measuring how a certain non-toxic dye was eliminated by the liver shortly after surgery was an accurate indicator of liver function, and therefore a reliable indicator of the outcome of the procedure. The study used a simple non-invasive device to measure the dye, making it particularly useful in treating transplant patients.

The results of this study appear in the April 2006 issue of Liver Transplantation, the official journal of the American Association for the Study of Liver Diseases (AASLD) and the International Liver Transplantation Society (ILTS). The journal is published on behalf of the societies by John Wiley & Sons, Inc. and is available online via Wiley InterScience at http://www.interscience.wiley.com/journal/livertransplantation.

Monitoring liver function following LDLT is crucial and identifying poor function as early as possible would be a step in the right direction toward achieving better outcomes. Since tests traditionally used to measure liver function are not always conclusive, researchers led by Tomohide Hori of Mie University in Tsu City, Japan analyzed how indocyanine green (ICG), a non-toxic dye, was processed by the liver, assessed a non-invasive method of measuring its levels, and determined whether such a test would be a reliable indicator of outcome.

The study involved 30 adult recipients who underwent LDLT between June 2003 and February 2005 at Mie University Hospital. The patients were divided into two groups based on liver function and outcome following the transplant (as measured by traditional methods such as bilirubin concentration). Group I consisted of 24 recipients who had good clinical outcomes while group II consisted of 6 recipients who needed intensive clinical management and had poor clinica
'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
4-Apr-2006

Page: 1 2 3
Related medicine news :

1. Predicting danger of flu pandemic rests on differences in affected population, says O.R. Forum
2. Predicting the quality of life for older adults
3. Predicting the risk of rheumatoid arthritis for early arthritis patients
4. Predicting an answer to the threat of flooding
5. Predicting outcomes for kidney transplant patients
6. Predicting cardiovascular problems in liver transplant patients
7. Predicting the risk of death in patients with known coronary artery disease
8. Predicting the future of primary care in England
9. Predicting the outcome of drug-induced liver disease
10. Predicting serious cardiac outcomes
11. Physician-researchers often less successful in obtaining NIH funding